Incyte Corp. diskutieren
Incyte Corp.
WKN: 896133 / Symbol: INCY / Name: Incyte / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
49,63 €
1,68 %
(Stop Loss Kurs erreicht)
skatcup stimmt dem Crowdsentiment von 'Buy' zu
skatcup stimmt am 30.06.2019 dem Buy-Crowdsentiment mit dem Kursziel 117.0$ zu.
(Vom Mitglied beendet)
Buy Incyte Corp.
Incyte (NASDAQ:INCY) perks up 2% premarket on light volume on the heels of its announcement of positive results from a second Phase 3 clinical trial, TRuE-AD1, evaluating ruxolitinib cream 0.75% or 1.5% in patients at least 12 years old with mild-to-moderate atopic dermatitis (AD). The study met the primary endpoint of a statistically significant proportion of treated patients achieving clear or almost clear skin at week 8 compared to vehicle (placebo). A sister Phase 3, TRuE-AD2, was also successful. Marketing applications should be the next step.
Buy Incyte Corp.
Sell Incyte Corp.
Kursziel geändert auf 100,0
Kursziel geändert auf 118,0
Buy Incyte Corp.
Buy Incyte Corp.
Buy mit Kursziel 110,0
Buy mit Kursziel 60,0
Sell Incyte Corp.
Sell Incyte Corp.
Sell Incyte Corp.
Sell Incyte Corp.
Sell Incyte Corp.
Sell Incyte Corp.
Neueste Beiträge
ValueFreak in Tesla Inc diskutieren